DOYLE JOHN BRENDAN (Chief Financial Officer) reported 1 transaction at COGNITION THERAPEUTICS INC
Review the transaction codes below to understand the nature of each event.
Filed: 2/18/2025ACC: 0001062993-25-002703
Officer· Chief Financial Officer
Since Feb 2026
-1.72K
Net shares
Net seller
$1.0K
Total sold
0
Open market trades
0B · 0S
1
Total transactions
1.72K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−1.72K
Price / share
$0.59
Trade value
$1.02K
% of position
0.4%
2/15/2025
416.13K→414.40K
Total
Net shares
−1.72K
Net value
-$1.02K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 2/15/2025 | F · Tax Withholding | −1.72K | $0.59 | $1.02K | 0.4% | 416.13K | 414.40K |
| Total | −1.72K | -$1.02K | ||||||
Derivative Transactions0
No derivative transactions reported